Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 465
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Pharmazie ; 77(2): 45-47, 2022 02 01.
Artículo en Inglés | MEDLINE | ID: mdl-35209962

RESUMEN

Triple-negative breast cancer (TNBC) can be divided into six subtypes. Among these subtypes, the basal-like 2 (BL2) subtype shows the lowest five-year survival rate and highest risk of metastasis. Alpha-crystallin B chains (αB-crystallin), a small heat shock protein that is known to be involved in breast cancer metastasis, is highly expressed in the basal-like subtype but not in the other non-basal subtypes. Thus, we hypothesized that αB-crystallin may be an important factor involved in the worse prognosis of the BL2 subtype compared with those of the other TNBC subtypes. Here, we examined the role of αB-crystallin in cell motility in two TNBC cell lines: HCC1806 (BL2 subtype) and, as control, MDA-MB-436 (mesenchymal stem-like subtype). HCC1806 showed greater cell migration capacity and a higher expression level of the gene encoding αB-crystallin (CRYAB) than did MDA-MB-436. Short interfering RNA-mediated silencing of CRYAB expression significantly reduced the cell migration capacity of HCC1806 cells, whereas it had no effect in MDA-MB-436 cells, indicating that αB-crystallin is essential for the migration of HCC1806 cells. Thus, high αB-crystallin expression may be a contributing factor to the poor prognosis of BL2 TNBC.


Asunto(s)
Movimiento Celular , Neoplasias de la Mama Triple Negativas , Cadena B de alfa-Cristalina , Humanos , Pronóstico , Neoplasias de la Mama Triple Negativas/genética , Neoplasias de la Mama Triple Negativas/metabolismo , Cadena B de alfa-Cristalina/genética , Cadena B de alfa-Cristalina/metabolismo
2.
Pharmazie ; 76(12): 602-605, 2021 12 05.
Artículo en Inglés | MEDLINE | ID: mdl-34986956

RESUMEN

Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) provide a favorable treatment outcome in patients with EGFR mutation-positive non-small cell lung cancer. However, most of such patients become resistant to EGFR-TKIs within a year. Thus, clarifying the mechanism of acquired resistance to EGFR-TKIs has been a research focus. Here, we demonstrated that the expression of progesterone receptor membrane component 2 (PGRMC2) was upregulated in an erlotinib-resistant cell line, PC9/ER, compared with the parental PC9 lung cancer cells. Our previous study showed that PGRMC1 is responsible for acquired resistance to erlotinib; however, PGRMC2 has not been discussed yet. Thus, the aim of this study was to determine the role of PGRMC2 in acquired resistance to erlotinib. Transfection with PGRMC2 siRNA significantly enhanced the sensitivity to erlotinib in PC9/ER cells. Furthermore, knockdown of PGRMC2 reduced the expression of p21, which is known as cell-cycle inhibitor and antiproliferative effector. These results suggest that PGRMC2 partially contributes to erlotinib resistance in PC9/ER cells, and that investigation into the effect of PGRMC2 on apoptosis and the cell cycle are warranted.


Asunto(s)
Adenocarcinoma del Pulmón , Carcinoma de Pulmón de Células no Pequeñas , Neoplasias Pulmonares , Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico , Carcinoma de Pulmón de Células no Pequeñas/genética , Carcinoma de Pulmón de Células no Pequeñas/patología , Línea Celular Tumoral , Resistencia a Antineoplásicos/genética , Receptores ErbB , Clorhidrato de Erlotinib/farmacología , Humanos , Neoplasias Pulmonares/tratamiento farmacológico , Neoplasias Pulmonares/genética , Neoplasias Pulmonares/metabolismo , Proteínas de la Membrana/genética , Mutación , Inhibidores de Proteínas Quinasas/farmacología , Receptores de Progesterona/genética , Transducción de Señal
3.
Br J Surg ; 106(5): 606-615, 2019 04.
Artículo en Inglés | MEDLINE | ID: mdl-30883708

RESUMEN

BACKGROUND: The benefit of taking intra-abdominal cultures during source control procedures in patients with complicated intra-abdominal infection (CIAI) is unknown. The aim of this study was to evaluate whether intra-abdominal cultures reduce the mortality rate of CIAI. METHODS: The Japanese Diagnosis Procedure Combination database was used to identify adult patients with CIAI who had undergone source control procedures on the first day of admission to hospital between April 2014 and March 2016. In-hospital mortality was compared between patients who did and those who did not have intra-abdominal cultures taken. A generalized linear mixed-effect logistic regression model and a random intercept per hospital were used to adjust for baseline confounders and institutional differences. Subgroup analyses were also performed according to disease cause, site of onset and severity of CIAI. RESULTS: Intra-abdominal cultures were taken from 16 303 of 41 495 included patients. Multivariable logistic regression analysis showed that patients with intra-abdominal cultures had a significantly lower mortality than those without (odds ratio 0·85, 95 per cent c.i. 0·77 to 0·95). Subgroup analyses revealed statistically significant differences in mortality between patients with and without cultures among those with lower intestinal perforation, biliary tract infection/perforation, healthcare-associated CIAI and high-risk community-acquired CIAI. CONCLUSIONS: Intra-abdominal cultures obtained during source control procedures may reduce in-hospital mortality, especially in patients with lower intestinal perforation, biliary tract infection/perforation, or healthcare-associated or high-risk community-acquired CIAI.


Asunto(s)
Técnicas Bacteriológicas/estadística & datos numéricos , Infecciones Intraabdominales/microbiología , Infecciones Intraabdominales/mortalidad , Adulto , Anciano , Anciano de 80 o más Años , Antiinfecciosos/uso terapéutico , Enfermedades de las Vías Biliares/complicaciones , Enfermedades de las Vías Biliares/microbiología , Femenino , Mortalidad Hospitalaria , Humanos , Perforación Intestinal/complicaciones , Perforación Intestinal/microbiología , Infecciones Intraabdominales/complicaciones , Infecciones Intraabdominales/tratamiento farmacológico , Japón , Masculino , Persona de Mediana Edad , Utilización de Procedimientos y Técnicas , Perforación Espontánea/complicaciones , Perforación Espontánea/microbiología
4.
Pharmazie ; 74(10): 614-619, 2019 10 01.
Artículo en Inglés | MEDLINE | ID: mdl-31685088

RESUMEN

Exosomes are potent players in the development of metastases and they play an important role in cancer angiogenesis and exacerbation. However, it is unclear how proteins on exosomes affect development of blood vessel networks. In this study, we focused on relationships between membrane proteins on exosomes and angiogenesis using human umbilical vein endothelial cells (HUVEC). Lung tumor cell-derived exosomes induced tube formation and growth of endothelial cells in vitro in a dose-dependent manner involving MAPK activation, but this was not seen in normal lung epithelial cells. Ephrin type-A receptor 2 (EphA2) was identified by proteomic analysis and an inhibition assays showed it is a major MAPK activator on exosomes. Thus EphA2 on exosomes participates in angiogenesis as a ligand of the ephrin signaling pathway. These results support the development of novel therapeutic strategies such as blockade of remote cancer communications through exosomes.


Asunto(s)
Efrina-A2/metabolismo , Exosomas/metabolismo , Neoplasias Pulmonares/irrigación sanguínea , Sistema de Señalización de MAP Quinasas , Inductores de la Angiogénesis , Línea Celular Tumoral , Células Epiteliales/metabolismo , Células Endoteliales de la Vena Umbilical Humana , Humanos , Neoplasias Pulmonares/metabolismo , Proteína Quinasa 3 Activada por Mitógenos/metabolismo , Neovascularización Patológica/metabolismo , Neovascularización Patológica/patología , Cultivo Primario de Células , Receptor EphA2 , Receptor 2 de Factores de Crecimiento Endotelial Vascular/metabolismo
5.
J Assist Reprod Genet ; 35(5): 899-905, 2018 May.
Artículo en Inglés | MEDLINE | ID: mdl-29357025

RESUMEN

PURPOSE: In human oocytes, sERCs are one of the dysmorphic phenotypes that have been reported. Significantly reduced pregnancy rates and a comparatively higher number of abnormities in live births appear to be associated with the presence of sERCs in oocytes. However, some reports have shown that healthy babies can be born, without any reduced pregnancy rates, from oocytes observed to contain sERCs. Thus, the clinical and scientific significance of oocytes that harbor sERCs remains controversial. METHODS: The presence of sERCs was evaluated using a time-lapse system while studying the dynamic changes within oocytes and embryos. Logistic regression analysis was carried out to explore the independent variables for meiotic and mitotic cleavage failure.. RESULTS: The incidence of mitotic cleavage failure and the incidence of meiotic cleavage failure during the second polar body extrusion in oocytes with sERCs were found to be significantly higher than that in oocytes without sERCs. Furthermore, ICSI was found to have a greater frequency of meiotic failure than IVF. CONCLUSIONS: In cases of cleavage failure, an embryonic cell could become tetraploid and may induce abnormal chromosomal configurations. Some cells exposed to cleavage failure may become trophectoderm cells and form placental abnormalities. Even if they develop into trophectoderm cells, the ICM can be susceptible to further cleavage failure and may in turn cause further aneuploidy. For these reasons, it is important to monitor pregnancies and births derived from oocytes that contained sERCs.


Asunto(s)
Retículo Endoplásmico Liso/patología , Fertilización In Vitro/métodos , Oocitos/patología , Adulto , Femenino , Humanos , Meiosis , Inyecciones de Esperma Intracitoplasmáticas/métodos , Imagen de Lapso de Tiempo , Resultado del Tratamiento
6.
Pharmazie ; 72(1): 10-16, 2017 Jan 10.
Artículo en Inglés | MEDLINE | ID: mdl-29441891

RESUMEN

Nanomaterials are frequently used in microelectronics, cosmetics, and sunscreens. Platinum reagents are commonly used in disease diagnosis, cosmetics, and the food industry. Although research into the development of nanomaterialbased drug delivery systems has yielded promising results, the toxicity of these materials is not fully understood. We investigated the toxicity and drug interactions of 1- and 8-nm diameter platinum nanoparticles (nPt1 and nPt8, respectively) in mice. Acute hepato-renal toxicity of intravenously administered platinum nanoparticles was evaluated biochemically and histologically. Dose-dependent increases in serum markers of hepato-renal function (serum aminotransferases and blood urea nitrogen) were observed following administration of nPt1, whereas nPt8 had no effect, even at 20 mg/kg. Moreover, nPt1 induced interleukin (IL)-6 and IL-1ß production 3 and 6 hours after administration. The effect of nPts on drug-induced toxicity was evaluated in mice injected intraperitoneally with carbon tetrachloride or cisplatin, with or without intravenous administration of platinum nanoparticles. All treatments in the absence of nanoparticles were non-lethal and resulted in moderate toxicity. However, exacerbated toxicity was observed in mice injected with carbon tetrachloride or cisplatin together with nPt1, but not in mice co-injected with nPt8. We found that nPt1 cause hepato-renal damage, and the effect is enhanced by chemical inducers of hepatotoxicity and nephrotoxicity. This is the first report demonstrating that nPt1 not only are hepatotoxic and nephrotoxic but also exacerbate drug toxicity. These findings will be useful for future nanotechnology and nanoscience research.


Asunto(s)
Enfermedad Hepática Inducida por Sustancias y Drogas/patología , Enfermedades Renales/inducido químicamente , Enfermedades Renales/patología , Nanopartículas del Metal/toxicidad , Platino (Metal)/toxicidad , Alanina Transaminasa/sangre , Animales , Antineoplásicos/toxicidad , Aspartato Aminotransferasas/sangre , Nitrógeno de la Urea Sanguínea , Tetracloruro de Carbono/toxicidad , Cisplatino/toxicidad , Relación Dosis-Respuesta a Droga , Interacciones Farmacológicas , Interleucina-1beta/biosíntesis , Interleucina-1beta/genética , Interleucina-6/biosíntesis , Interleucina-6/genética , Masculino , Ratones , Ratones Endogámicos BALB C , Tamaño de la Partícula
7.
Clin Exp Allergy ; 46(7): 992-1003, 2016 07.
Artículo en Inglés | MEDLINE | ID: mdl-26892276

RESUMEN

BACKGROUND: The relationship among natural allergen exposure, induction of blocking antibody and the occurrence of atopic allergy-particularly in the presence of IgE production-is debatable. OBJECTIVE: To clarify the relationship between the dose of cutaneous exposure to dust mite allergen and susceptibility to the IgE-mediated allergic response in relation to IgG production. METHODS: NC/Nga mice were epicutaneously exposed to various doses of Dermatophagoides pteronyssinus allergen to induce atopic dermatitis-like skin lesions. We then evaluated the skin lesions, induction of mite-specific immune responses, and susceptibility to anaphylaxis. RESULTS: Dose-dependent exacerbation of atopic dermatitis-like skin lesions and increases in mite-specific IgG and IgE production were observed. However, mice exposed to relatively low doses of mite allergen showed hypersusceptibility to mite allergen-specific anaphylaxis. We also showed that adoptive transfer of total IgG from Dp-sensitized mice rescued mice from the hypersusceptibility seen in those exposed to low doses of mite allergen. CONCLUSIONS AND CLINICAL RELEVANCE: High-dose cutaneous exposure to dust mites induced effective blocking IgG production, even if accompanied by IgE production. Our data might support the concept that an increase in IgG titre, not a decrease in IgE titre, is a marker of clinical improvement in allergen-specific immunotherapy.


Asunto(s)
Alérgenos/administración & dosificación , Alérgenos/inmunología , Anafilaxia/prevención & control , Anticuerpos Bloqueadores/inmunología , Antígenos Dermatofagoides/administración & dosificación , Antígenos Dermatofagoides/inmunología , Inmunoglobulina G/inmunología , Anafilaxia/inmunología , Anafilaxia/metabolismo , Animales , Especificidad de Anticuerpos/inmunología , Citocinas/metabolismo , Modelos Animales de Enfermedad , Femenino , Inmunización , Inmunoglobulina E/sangre , Inmunoglobulina E/inmunología , Inmunoglobulina G/sangre , Ratones
8.
Pharmazie ; 71(5): 235-7, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-27348964

RESUMEN

Tumor necrosis factor (TNF)/TNF receptors (TNFR1/TNFR2) are considered to be potential drug targets to treat refractory diseases, including autoimmune diseases and malignant tumors. However, their specific functions, especially in the case of TNFR2, are poorly understood. In this study, we constructed a mouse TNFR2 (mTNFR2)-mediated biological assay system that shows no effects of mouse TNFR1 (mTNFR1) in order to screen mTNFR2-selective stimulating agents. Mouse TNFR1(-/-)R2(-/-) preadipocytes were transfected with the gene encoding the mTNFR2/mouse Fas (mFas) chimeric receptor in which the extracellular and transmembrane domains of mTNFR2 were fused to the intracellular domain of mFas. Our results demonstrated that this cell line exhibits highly sensitive mTNFR2-mediated cytotoxic effects. We propose that this mTNFR2-mediated biological assay system would be a useful tool to screen for mTNFR2-selective stimulating agents.


Asunto(s)
Adipocitos/citología , Receptores Tipo II del Factor de Necrosis Tumoral/genética , Receptores Tipo I de Factores de Necrosis Tumoral/genética , Receptor fas/genética , Animales , Bioensayo/métodos , Línea Celular , Ratones , Ratones Noqueados , Receptores Tipo I de Factores de Necrosis Tumoral/efectos de los fármacos , Receptores Tipo II del Factor de Necrosis Tumoral/efectos de los fármacos , Transfección
9.
Acta Anaesthesiol Scand ; 58(8): 948-54, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24780066

RESUMEN

BACKGROUND: During perioperative fasting, lipid metabolism gradually increases, resulting in free fatty acids (FFA) and/or ketone bodies. Suppression of surgical stress by remifentanil may allow the safe administration of glucose infusions, avoiding both hyperglycemia and ketogenesis. The effects of glucose infusion on glucose and lipid metabolism were therefore investigated in patients undergoing minor surgery with remifentanil anesthesia. METHODS: Thirty-four patients were randomized 1 : 1 to receive no glucose (0G group) or low-dose glucose (0.1 g/kg/h for 1 h followed by 0.05 g/kg/h for 1 h; LG group). The concentrations of glucose, adrenocorticotropic hormone (ACTH), 3-methylhistidine (3-MH), insulin, cortisol, FFA, creatinine (Cr), and ketone bodies were measured before anesthetic induction, 1 and 2 h after glucose infusion, at the end of surgery, and the next morning. RESULTS: The concentrations of cortisol and ACTH decreased during surgery in both groups when compared with the concentrations before anesthesia and at the end of surgery (P < 0.05). Glucose and insulin concentrations were significantly higher in the LG than in the 0G group at 1 and 2 h after infusion. No patient experienced hyperglycemia. The concentrations of FFA and ketone bodies were lower in the LG than in the 0G group during surgery, but there were no significant between group differences in 3-MH/Cr. CONCLUSION: Infusion of low-dose glucose attenuated fat catabolism without causing hyperglycemia, indicating that infusion of low-dose glucose during remifentanil-induced anesthesia may be safe for patients.


Asunto(s)
Ácidos Grasos no Esterificados/sangre , Glucosa/farmacología , Complicaciones Intraoperatorias/sangre , Cuerpos Cetónicos/sangre , Piperidinas/efectos adversos , Hormona Adrenocorticotrópica/sangre , Adulto , Androstanoles/efectos adversos , Creatina/sangre , Femenino , Glucosa/administración & dosificación , Humanos , Hidrocortisona/sangre , Hiperglucemia/prevención & control , Infusiones Intravenosas , Insulina/sangre , Complicaciones Intraoperatorias/prevención & control , Metabolismo de los Lípidos , Masculino , Metilhistidinas/sangre , Persona de Mediana Edad , Remifentanilo , Rocuronio , Método Simple Ciego , Tiamilal/efectos adversos
10.
Pharmazie ; 68(3): 178-82, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23556335

RESUMEN

Nano-sized materials are widely used in consumer products, medical devices and engineered pharmaceuticals. Advances in nanotechnology have resulted in materials smaller than the nanoscale, but the biologic safety of the sub-nanosized materials has not been fully assessed. In this study, we evaluated the toxic effects of sub-nanosized platinum particles (snPt) in the mouse liver. After intravenous administration of snPt (15 mg/kg body weight) into mice, histological analysis revealed acute hepatic injury, and biochemical analysis showed increased levels of serum markers of liver injury and inflammatory cytokines. In contrast, administration of nano-sized platinum particles did not produce these abnormalities. Furthermore, snPt induced cytotoxicity when directly applied to primary hepatocytes. These data suggest that snPt have the potential to induce hepatotoxicity. These findings provide useful information on the further development of sub-nanosized materials.


Asunto(s)
Enfermedad Hepática Inducida por Sustancias y Drogas/patología , Platino (Metal)/toxicidad , Alanina Transaminasa/sangre , Animales , Aspartato Aminotransferasas/sangre , Supervivencia Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Hepatocitos/efectos de los fármacos , Hepatocitos/patología , Hígado/patología , Pruebas de Función Hepática , Masculino , Ratones , Ratones Endogámicos BALB C , Nanopartículas/toxicidad , Tamaño de la Partícula , Platino (Metal)/administración & dosificación
11.
Pharmazie ; 68(12): 969-73, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24400444

RESUMEN

Detection of drug-target proteins and biomarkers that are expressed in cancer tissue has significant potential for both diagnosis and treatment of cancer. However, current immuno-histochemical and cytogenetic analyses of biopsy specimens for pre-operational diagnosis are highly invasive and often difficult to apply to lung cancer patients. The purpose of this study was to evaluate the possible utility of determining epidermal growth factor receptor (EGFR) expression on exosomal membranes using a targeted ELISA with an anti-CD81 antibody as a capture antibody for lung cancer diagnosis. While soluble EGFR (sEGFR) levels in plasma were not remarkably different between lung cancer patients and normal controls, significantly higher exosomal EGFR expression levels were observed in 5/9 cancer cases compared to normal controls. These results suggest that measurement of exosomal protein levels could be useful for in vitro diagnosis, and that exosomal EGFR is a possible biomarker for characterization of lung cancer.


Asunto(s)
Biomarcadores/análisis , Receptores ErbB/metabolismo , Exosomas/metabolismo , Neoplasias Pulmonares/diagnóstico , Adulto , Anciano , Animales , Western Blotting , Línea Celular Tumoral , Medios de Cultivo Condicionados , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Inmunohistoquímica , Masculino , Membranas/metabolismo , Ratones , Ratones Endogámicos BALB C , Microscopía Electrónica , Persona de Mediana Edad , Plásmidos , Tetraspanina 28/metabolismo
12.
Pharmazie ; 68(1): 54-7, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23444781

RESUMEN

The fullerene C60 is used in consumer products such as cosmetics owing to its antioxidative effects and is being developed for nanomedical applications. However, knowledge regarding the safety of fullerene C60, especially after oral administration, is sparse. Here, we examined the safety of fullerene C60 in mice after 7 d of exposure to orally administered polyvinylpyrrolidone (PVP)-wrapped fullerene C60 (PVP-fullerene C60). Mice treated with PVP-fullerene C60 showed few changes in the plasma levels of various markers of kidney and liver injury and experienced no significant hematologic effects. Furthermore, the histology of the colon of PVP-fullerene C60-treated mice was indistinguishable from that of control mice. These results suggest that PVP-fullerene C60 lacks toxicity after high-dose oral administration and indicate that PVP-fullerene C60 can be considered safe for oral medication. These data provide basic information that likely will facilitate the production of safe and effective forms of fullerene C60.


Asunto(s)
Fulerenos/farmacología , Lesión Renal Aguda/inducido químicamente , Lesión Renal Aguda/patología , Administración Oral , Animales , Recuento de Células Sanguíneas , Enfermedad Hepática Inducida por Sustancias y Drogas/patología , Colitis/inducido químicamente , Colitis/patología , Femenino , Fulerenos/administración & dosificación , Luz , Ratones , Ratones Endogámicos C57BL , Povidona , Dispersión de Radiación , Fijación del Tejido
13.
Phys Rev Lett ; 108(15): 157002, 2012 Apr 13.
Artículo en Inglés | MEDLINE | ID: mdl-22587277

RESUMEN

The field-orientation dependent thermal conductivity of the heavy-fermion superconductor UPt3 was measured down to very low temperatures and under magnetic fields throughout the distinct superconducting phases: B and C phases. In the C phase, a striking twofold oscillation of the thermal conductivity within the basal plane is resolved reflecting the superconducting gap structure with a line of node along the a axis. Moreover, we find an abrupt vanishing of the oscillation across a transition to the B phase, as a clear indication of a change of gap symmetries. We also identify extra two line nodes below and above the equator in both B and C phases. From these results together with the symmetry consideration, the gap function of UPt3 is determined as a E(1u) representation characterized by a combination of two line nodes at the tropics and point nodes at the poles.

14.
Pharmacopsychiatry ; 45(4): 133-7, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22174025

RESUMEN

INTRODUCTION: While patients with schizophrenia are often treated with psychotropic polypharmacy, how and when polypharmacy begins is not well documented. METHODS: A systematic chart review of 300 patients, 100 of whom were psychotropic-free prior to their first visit, was conducted to examine 2-year longitudinal prescription patterns of concomitant psychotropics, in addition to a primary antipsychotic. RESULTS: Overall polypharmacy occurred in 79% patients, with 2-year rates of the use of hypnotics, benzodiazepine derivative anxiolytics, anticholinergic drugs, antidepressants, and mood stabilizers were 56.7, 49.7, 38.3, 21.3, and 14.0%, respectively. Once polypharmacy had started, it was continued until their final visit in >70% of the patients. In a subgroup of 100 psychotropic-free patients, mood stabilizers, antidepressants, anticholinergic antiparkinsonian drugs, anxiolytics, and hypnotics were initiated after 2.3, 2.3, 2.1, 1.6, and 1.5 antipsychotics had been prescribed, respectively (mean duration before the introduction of a concomitant drug in days: 17.7, 121.6, 86.4, 32.1, and, 57.7, respectively). CONCLUSION: Routine practice deviates significantly from algorithms--with polypharmacy often being initiated early, often a without trial of other options, and once started commonly stays.


Asunto(s)
Antipsicóticos/uso terapéutico , Polifarmacia , Esquizofrenia/tratamiento farmacológico , Adulto , Ansiolíticos/uso terapéutico , Antidepresivos/uso terapéutico , Femenino , Humanos , Hipnóticos y Sedantes/uso terapéutico , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Resultado del Tratamiento , Adulto Joven
15.
Pharmazie ; 67(8): 742-3, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22957443

RESUMEN

The skin penetration and cellular localization of well-dispersed amorphous nanosilica particles (nSPs) with a diameter of 70 nm was analyzed in mice. Our results suggest that after topical exposure for three days the particles penetrate the skin barrier and are transported to the lymph nodes. These findings underscore the need to examine biological effects following dermal exposure to nSPs for the development of safer use of nSPs.


Asunto(s)
Nanopartículas , Dióxido de Silicio/farmacocinética , Absorción Cutánea/fisiología , Administración Cutánea , Administración Tópica , Animales , Oído Externo/metabolismo , Ratones , Ratones Endogámicos BALB C , Microscopía Electrónica de Transmisión , Nanopartículas/administración & dosificación , Dióxido de Silicio/administración & dosificación , Suspensiones
16.
Pharmazie ; 67(8): 740-1, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22957442

RESUMEN

Generation of total intracellular reactive oxygen species (ROS) was measured in XS52 cells, a Langerhans cell-like line, treated with different sized amorphous silica particles. The results suggested that exposure to amorphous nanosilica particles (nSPs) with a particle size of 70 nm induced a higher level of ROS generation than did exposure to micron-sized amorphous silica particles. This finding means that it is essential to examine the biological effects of ROS generated after exposure to nSPs, which will provide useful information for hazard identification as well as the design of safer nanomaterials.


Asunto(s)
Células de Langerhans/metabolismo , Nanopartículas/toxicidad , Especies Reactivas de Oxígeno/metabolismo , Dióxido de Silicio/toxicidad , Línea Celular , Humanos , Células de Langerhans/efectos de los fármacos , Tamaño de la Partícula
17.
Pharmazie ; 67(3): 253-5, 2012 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-22530308

RESUMEN

Since metastasis is one of the most important prognostic factors in colorectal cancer, development of new methods to diagnose and prevent metastasis is highly desirable. However, the molecular mechanisms leading to the metastatic phenotype have not been well elucidated. In this study, a proteomics-based search was carried out for metastasis-related proteins in colorectal cancer by analyzing the differential expression of proteins in primary versus metastasis focus-derived colorectal tumor cells. Protein expression profiles were determined using a tissue microarray (TMA), and the results identified Rho GDP-dissociation inhibitor alpha (Rho GDI) as a metastasis-related protein in colon and prostate cancer patients. Consequently, Rho GDI may be useful as a diagnostic biomarker and/or a therapeutic to prevent colon and prostate cancer metastasis.


Asunto(s)
Neoplasias del Colon/secundario , Inhibidores de Disociación de Guanina Nucleótido/fisiología , Neoplasias de la Próstata/secundario , Anciano , Western Blotting , Línea Celular Tumoral , Cromatografía Líquida de Alta Presión , Electroforesis en Gel Bidimensional , Colorantes Fluorescentes , Geles , Gliceraldehído-3-Fosfato Deshidrogenasas/metabolismo , Humanos , Hidrólisis , Inmunohistoquímica , Masculino , Espectrometría de Masas , Análisis por Micromatrices , Persona de Mediana Edad , Tripsina/química , Inhibidores de la Disociación del Nucleótido Guanina rho-Específico
18.
Lupus ; 20(8): 871-5, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21415254

RESUMEN

Hemophagocytic syndrome (HPS) is a serious complication of systemic lupus erythematosus (SLE). A 15-year-old female with lupus-nephritis developed HPS. Bone marrow study showed florid thrombophagocytosis. There was no associated infection. High-dose methylprednisolone therapy ameliorated HPS. However, atrial fibrillation (Af) repeated after the infusion and required direct-current cardioversion. No underlying diseases were found in the heart and endocrine system. Chest roentgenogram and echocardiography were normal. Electrocardiogram showed slightly prolonged PR interval in sinus rhythm. Af occurred at high circulating levels of interferon-γ and interleukin (IL)-10, but not IL-6, IL-2, tumor necrosis factor-α, C-reactive protein or catecholamines. This is the first observation that high-dose corticosteroid induced Af in a case of lupus-HPS. Af is unusual in SLE children without cardiac disease, while conduction defect occurs associated with lupus-myocarditis. Lupus-HPS may be an aggressive SLE subset with cardiac involvement. High-dose corticosteroid infusion controls lupus activity, but could disclose the cardiac stress in lupus-HPS patients.


Asunto(s)
Fibrilación Atrial/inducido químicamente , Glucocorticoides , Lupus Eritematoso Sistémico , Linfohistiocitosis Hemofagocítica , Metilprednisolona , Adolescente , Médula Ósea/patología , Proteína C-Reactiva/metabolismo , Catecolaminas/sangre , Citocinas/sangre , Femenino , Glucocorticoides/efectos adversos , Glucocorticoides/uso terapéutico , Humanos , Lupus Eritematoso Sistémico/complicaciones , Lupus Eritematoso Sistémico/tratamiento farmacológico , Linfohistiocitosis Hemofagocítica/tratamiento farmacológico , Linfohistiocitosis Hemofagocítica/etiología , Metilprednisolona/efectos adversos , Metilprednisolona/uso terapéutico
19.
Eur J Neurol ; 18(3): 425-9, 2011 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-20666834

RESUMEN

OBJECTIVE: Olfactory dysfunction is a non-motor symptom in idiopathic Parkinson's disease (PD). We investigated whether this dysfunction differs among clinical subtypes of PD. METHODS: Participants comprised of 90 patients with idiopathic PD and without dementia. Olfactory function was evaluated using the odor stick identification test for Japanese, which evaluated the detection of 12 odorants familiar to Japanese participants. Patients were divided into tremor-dominant type (TDT), akinetic-rigid type (ART), and mixed type (MXT) PD subgroups using part III of the Unified Parkinson's Disease Rating Scale. RESULTS: Fifty-five patients were classified as ART, 21 as MXT, and 14 as TDT. There were no differences in age, sex, or duration of illness among the subtypes. Subjective symptoms of impaired sense of smell were significantly higher (P<0.05) in the ART than in the TDT. Mean odor identification score was 4.3 in the ART, 5.2 in MXT, and 6.6 in TDT. It was significantly lower in the ART than in the TDT (P<0.01). CONCLUSION: Olfactory dysfunction differed among the clinical subtypes of PD. This suggests that olfactory function might relate to prognosis of patients with PD.


Asunto(s)
Trastornos del Olfato/etiología , Enfermedad de Parkinson/complicaciones , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana Edad , Odorantes , Enfermedad de Parkinson/fisiopatología , Pronóstico , Olfato/fisiología
20.
Anaesthesia ; 66(6): 515-8, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21457154

RESUMEN

Paraneoplastic limbic encephalitis associated with ovarian teratoma has recently been related to the development of antibodies to specific heteromers of the N-methyl-d-aspartate receptor and exhibits various manifestations including psychiatric symptoms, hypoventilation, seizures and derangement of autonomic nervous system function. Although recovery can sometimes occur spontaneously, early tumour resection with immunotherapy facilitates earlier recovery. Herein, we describe anaesthetic management of a 20-year-old woman who developed general convulsions and decreased level of consciousness, whom we suspected of having paraneoplastic limbic encephalitis and was scheduled for left ovarian tumour resection. Anaesthetic management was successful with no complications but the case acts as focus of discussion for the potential interaction of N-methyl-D-aspartate receptors and anaesthetic sensitivity.


Asunto(s)
Anestesia General/métodos , Encefalitis Límbica/etiología , Neoplasias Ováricas/cirugía , Receptores de N-Metil-D-Aspartato/inmunología , Teratoma/cirugía , Autoanticuerpos/análisis , Femenino , Humanos , Encefalitis Límbica/inmunología , Neoplasias Ováricas/complicaciones , Convulsiones/etiología , Teratoma/complicaciones , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA